Literature DB >> 29477055

Effect of gallic acid on purinergic signaling in lymphocytes, platelets, and serum of diabetic rats.

Aline da Silva Pereira1, Lizielle Souza de Oliveira1, Thauan Faccin Lopes1, Jucimara Baldissarelli2, Taís Vidal Palma1, Mayara Sandrielly Pereira Soares3, Luiza Spohr4, Vera Maria Morsch5, Cinthia Melazzo de Andrade6, Maria Rosa Chitolina Schetinger1, Roselia Maria Spanevello7.   

Abstract

Diabetes Mellitus (DM) is associated with an increased susceptibility to various infections, which might be attributed to changes in immune response owing to chronic hyperglycemia. Nucleoside triphosphate diphosphohydrolase (NTPDase), 5'-nucleotidase, and adenosine deaminase (ADA) are important enzymes involved in the generation of anti-aggregant and anti-inflammatory microenvironments. The aim of this study was to evaluate the effect of gallic acid (GA) on the hematological parameters and ectonucleotidase activities in platelets, lymphocytes, and serum of diabetic rats. Experimental rats were categorized into 4 groups: (i) control -saline, (ii) control - GA, (iii) diabetic -saline, and (iv) diabetic - GA. One week after induction of DM using streptozotocin (65 mg/kg), GA (30 mg/kg) or saline was orally administered to the rats for 21 days. Our results demonstrated that the concentration of mean corpuscular hemoglobin was decreased, whereas that of red cell distribution was increased in the diabetic group, however, GA could revert these alterations. Moreover, in diabetic rats, GA reverted the increase in ATP and ADP hydrolysis and ADA activity in lymphocytes, and it prevented the increase in NTPDase and ADA activities in platelets. A decrease in ATP hydrolysis and an increase in ADP and AMP hydrolysis were observed in the serum of diabetic rats; however, GA treatment could solely revert changes in ATP hydrolysis. Our study suggests that GA exhibits beneficial effects on immuno- and thrombo-regulatory responses in DM and that these effects may be related to the modulation of purinergic signaling.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Ectonucleotidases; Gallic acid; Lymphocytes; Platelets; Serum

Mesh:

Substances:

Year:  2018        PMID: 29477055     DOI: 10.1016/j.biopha.2018.02.029

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Ban-Xia-Xie-Xin-Tang.

Authors:  Ming Yang; Jialei Chen; Liwen Xu; Xiufeng Shi; Xin Zhou; Rui An; Xinhong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-16       Impact factor: 2.629

2.  Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.

Authors:  Alzahrani Abdullah; Mohammed Maged; Ibrahim Hairul-Islam M; Alwassil Osama I; Habash Maha; Alfuwaires Manal; Hanieh Hamza
Journal:  PLoS One       Date:  2019-04-26       Impact factor: 3.240

Review 3.  Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction.

Authors:  Zhichao Zhou
Journal:  Purinergic Signal       Date:  2021-08-19       Impact factor: 3.765

Review 4.  Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action.

Authors:  Kang Yang; Limeng Zhang; Pinfeng Liao; Zaili Xiao; Fan Zhang; Daniel Sindaye; Zhongquan Xin; Chengquan Tan; Jinping Deng; Yulong Yin; Baichuan Deng
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.